Nexelis

AIT Bioscience, LLC is a bioanalytical contract research organization based in Indianapolis, Indiana, specializing in providing comprehensive testing services to pharmaceutical and biotechnology companies. Founded in 2008, the company supports preclinical and clinical studies, including phases I to III trials. AIT Bioscience offers a range of services, including pharmacokinetics and toxicokinetics bioanalysis, biomarker analysis, and immunogenicity assays. Its capabilities encompass drug discovery analyses, ligand-binding assays, method development, and sample logistics for investigational drug applications. The company employs electronic systems for real-time quality control and monitoring, ensuring accurate and reliable results. AIT Bioscience develops and validates assays for various therapeutic molecules, including peptide drugs and antibody-based therapeutics, enhancing the drug development process. As of July 2020, AIT Bioscience operates as a subsidiary of Nexelis.

ImmunXperts SA is a biotechnology company based in Gosselies, Belgium, founded in 2014. The company specializes in developing bioassays that focus on the human immune system, offering a comprehensive range of services including immunogenicity, immuno-oncology, and cell therapy. ImmunXperts supports biopharma companies in the drug development process by providing in vitro immunology services that assess immune responses in donors and patients. Their offerings include immunogenicity screening, which evaluates the immunogenicity risk of biotherapeutics, as well as in silico, in vitro, and in vivo services. By enabling customers to outsource their immunology assessments, ImmunXperts helps clients select optimal lead candidates tailored to their specific requirements.